News & Insights

Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle

M&A and Public Offerings leaders, Andrew Luh, John Olson and Andrew Thorpe, hosted a webinar on unpacking the dual-track strategy and how company leaders can be prepared to pivot quickly between the IPO and M&A paths

Watch the webinar, "IPO Readiness: Setting the Stage for a Successful IPO" hosted by Jeff Vetter, Andy Thorpe and Alexa Belonick

Partners Alexa Belonick and Andy Thorpe and advisor Brett Pletcher host a webinar to build on their first discussion of the responsibilities typically assigned to the legal team and how the team can prepare as an IPO approaches

3E Network, a business-to-business information technology business solutions provider, announces its initial public offering.

Clinical stage biopharmaceutical company, Contineum Therapeutics, announces the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share.

Biopharmaceutical company, Tarsus Pharmaceuticals, announces its $115.0 million public offering to continue advancing its pipeline to address several diseases. 

Gunderson Dettmer is the winner of the “Team Collaboration Platform of the Year” award for its GDHQ in the 5th annual LegalTech Breakthrough Awards program conducted by LegalTech Breakthrough

Gunderson Dettmer fuels Generative AI education in venture capital. Explore diverse AI resources: articles, client insights, events, podcasts, and webinars – all enhancing your engagement with this dynamic field.

Gunderson Dettmer is recognized as the top venture capital law firm in Latin America by PitchBook Global League Tables in H1 2024